IL243894B - Molecular pharmacodynamic methods and biomarkers for multiple signaling pathways in response to carboxyamidotriazole orotate - Google Patents

Molecular pharmacodynamic methods and biomarkers for multiple signaling pathways in response to carboxyamidotriazole orotate

Info

Publication number
IL243894B
IL243894B IL243894A IL24389416A IL243894B IL 243894 B IL243894 B IL 243894B IL 243894 A IL243894 A IL 243894A IL 24389416 A IL24389416 A IL 24389416A IL 243894 B IL243894 B IL 243894B
Authority
IL
Israel
Prior art keywords
response
methods
signaling pathways
multiple signaling
pharmacodynamic biomarkers
Prior art date
Application number
IL243894A
Other languages
English (en)
Hebrew (he)
Other versions
IL243894A0 (en
Original Assignee
Tactical Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tactical Therapeutics Inc filed Critical Tactical Therapeutics Inc
Publication of IL243894A0 publication Critical patent/IL243894A0/en
Publication of IL243894B publication Critical patent/IL243894B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
IL243894A 2013-08-02 2016-02-01 Molecular pharmacodynamic methods and biomarkers for multiple signaling pathways in response to carboxyamidotriazole orotate IL243894B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/957,720 US10378059B2 (en) 2013-08-02 2013-08-02 Methods and molecular pharmacodynamic biomarkers for multiple signaling pathways in response to carboxyamidotriazole orotate
PCT/US2014/048905 WO2015017545A1 (en) 2013-08-02 2014-07-30 Methods and molecular pharmacodynamic biomarkers for multiple signaling pathways in response to carboxyamidotriazole orotate

Publications (2)

Publication Number Publication Date
IL243894A0 IL243894A0 (en) 2016-04-21
IL243894B true IL243894B (en) 2020-06-30

Family

ID=52428197

Family Applications (1)

Application Number Title Priority Date Filing Date
IL243894A IL243894B (en) 2013-08-02 2016-02-01 Molecular pharmacodynamic methods and biomarkers for multiple signaling pathways in response to carboxyamidotriazole orotate

Country Status (9)

Country Link
US (1) US10378059B2 (https=)
EP (1) EP3027776B1 (https=)
JP (1) JP6913459B2 (https=)
KR (1) KR102389934B1 (https=)
CN (1) CN105531380B (https=)
AU (1) AU2014296212B2 (https=)
CA (1) CA2919690C (https=)
IL (1) IL243894B (https=)
WO (1) WO2015017545A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10882841B2 (en) 2016-03-01 2021-01-05 University Of Maryland, Baltimore Wnt signaling pathway inhibitors for treatments of disease
JP6889009B2 (ja) * 2017-04-13 2021-06-18 浜松ホトニクス株式会社 画像取得システム及び画像取得方法
US20220168276A1 (en) * 2020-08-05 2022-06-02 Tactical Therapeotics Inc. Mehods and Compositions for Treating SARS-CoV-2 Infection using Carboxyamidotriazole Orotate

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69633566T2 (de) * 1995-07-21 2005-12-08 Savvipharm Inc. Orotatsalze von 5-amino- oder substituierten amino-1,2,3-triazolen zur behandlung von neoplasmen
US20030170720A1 (en) * 2001-01-23 2003-09-11 Van Der Kuyl Antoinette Cornelia Means and methods for treatment evaluation
US8137910B2 (en) 2002-05-03 2012-03-20 Duke University Method of regulating gene expression
US8450057B2 (en) 2006-08-14 2013-05-28 The Brigham And Women's Hospital, Inc. Diagnostic tests using gene expression ratios
US7750018B2 (en) * 2006-12-06 2010-07-06 Tactical Therapeutics, Inc Use of carboxiamidotriazole (CAI) orotate in macular degeneration
JP2010522567A (ja) 2007-03-28 2010-07-08 メダレックス インコーポレーティッド 遺伝子増幅および発現の方法
WO2009120561A2 (en) * 2008-03-22 2009-10-01 Merck & Co., Inc. Methods and gene expression signature for assessing growth factor signaling pathway regulation status
NZ598482A (en) * 2009-09-04 2014-05-30 Tactical Therapeutics Inc Novel compositions and processes for preparing 5-amino or substituted amino 1,2,3-triazoles and triazole orotate formulations
US8877785B2 (en) * 2009-09-04 2014-11-04 Tactical Therapeutics Inc Methods and compositions for enhancing sensitivity of cytotoxic drugs with timely combinatorial therapy with carboxyamidotriazole orotate
WO2012135845A1 (en) * 2011-04-01 2012-10-04 Qiagen Gene expression signature for wnt/b-catenin signaling pathway and use thereof

Also Published As

Publication number Publication date
EP3027776A4 (en) 2017-03-08
CA2919690C (en) 2021-11-02
EP3027776C0 (en) 2024-02-07
JP6913459B2 (ja) 2021-08-04
WO2015017545A1 (en) 2015-02-05
US20150038349A1 (en) 2015-02-05
EP3027776A1 (en) 2016-06-08
AU2014296212B2 (en) 2020-10-22
KR102389934B1 (ko) 2022-04-21
US10378059B2 (en) 2019-08-13
JP2016526908A (ja) 2016-09-08
HK1220493A1 (en) 2017-05-05
IL243894A0 (en) 2016-04-21
CN105531380B (zh) 2021-07-13
CA2919690A1 (en) 2015-02-05
EP3027776B1 (en) 2024-02-07
CN105531380A (zh) 2016-04-27
AU2014296212A1 (en) 2016-02-25
KR20160030535A (ko) 2016-03-18

Similar Documents

Publication Publication Date Title
IL244381A0 (en) Content-based image retrieval
EP2984556A4 (en) IDENTIFICATION OF CONTENT IN ELECTRONIC IMAGES
EP2974347A4 (en) DETERMINING INTERESTING LEVELS IN VIDEOS
ZA201602474B (en) Improvements in website traffic optimization
SG11201602075WA (en) Techniques for facilitating electronic trading
PL3537097T3 (pl) Urządzenie do formowania rowków w elementach rurowych
GB201613334D0 (en) Improvements in refrigerators
EP2956891A4 (en) OBJECT SEGMENTATION IN MULTIMEDIA DATA
EP2965227A4 (en) METADATA OF A TEMPLATE
GB2523727B (en) Stay in line
GB2525831B (en) Prefetching for parent core in multi-core chip
EP3072059A4 (en) Determining an action in response to an event
IL246403A0 (en) Methods and reagents for radioactive labeling
GB201309597D0 (en) Improvements in surfboards
IL243894A0 (en) Molecular pharmacodynamic methods and biomarkers for multiple signaling pathways in response to carboxyamidotriazole orotate
SI2972357T1 (sl) Postopek za odkrivanje molekul v vzorcu
GB201316207D0 (en) Improvements in or relating to data processing
GB201302190D0 (en) Data-processing system
GB201319552D0 (en) Document with verification data
GB201316095D0 (en) Motorcycle electronic side stand device
GB201303206D0 (en) Ownership Detection Method
GB201306564D0 (en) Improvements in scooters
GB201307426D0 (en) Improvements in or relating to openpath detection
BR302013002297S1 (pt) Configuração introduzida em bisnaga
BR302013002005S1 (pt) Configuração introduziada em bombona

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed